Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia

Rael D. Strous*, Rachel Maayan, Raya Lapidus, Rafael Stryjer, Michal Lustig, Moshe Kotler, Abraham Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

208 Scopus citations

Fingerprint

Dive into the research topics of 'Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience